Cantai Therapeutics
PrivateLast Round
Seed
Nov 20, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cantai Therapeutics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Seed round in November 2023.
Cantai Therapeutics is a biotechnology company that develops cytokine-targeting bispecific antibodies for the treatment of autoimmune and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantai Therapeutics Comparables
Compare Cantai Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualitas Therapeutics | 86% | |
| Navigator Medicines | 86% | |
| Ypsilon Therapeutics | 79% |
For institutional investors. Book with your work email.
Cantai Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cantai Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Seed |
| Tellus BioVentures | Seed |
| 82VS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 47% MoM.
- Nov 20, 2023
Led by 82VS and Agent Capital.
For institutional investors. Book with your work email.
Cantai Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cantai Therapeutics's valuation, stock price, and market status.
Is Cantai Therapeutics a public or private company?
Cantai Therapeutics is a private company.
What is the current stock price of Cantai Therapeutics?
Cantai Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cantai Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cantai Therapeutics worth (valuation)?
Valuation information for Cantai Therapeutics is not publicly available.
Can I buy Cantai Therapeutics stock?
Cantai Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cantai Therapeutics's last funding round?
Cantai Therapeutics's most recent funding round was Seed on November 20, 2023.
Who are the main investors in Cantai Therapeutics?
Key investors in Cantai Therapeutics include Agent Capital, 82VS.
Will Cantai Therapeutics IPO soon?
No public IPO plans have been announced for Cantai Therapeutics.
How can I track Cantai Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cantai Therapeutics's shares on secondary markets.